secwatch / observer
8-K filed May 23, 2025, 7:59 PM ET ticker PSTV CIK 0001095981
regulatory confidence high sentiment negative materiality 0.65

PLUS THERAPEUTICS, INC. (PSTV): Nasdaq/NYSE listing notice — Plus Therapeutics receives Nasdaq deficiency notice for late Q1 10-Q filing

PLUS THERAPEUTICS, INC.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

PLUS THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
late filing
Rules
5250(c)(1)
Exact text from the filing
May 21, 2025, Plus Therapeutics, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Quarterly Report”), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”). The Notice states that the Company has until July 21, 2025, to su
View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

PLUS THERAPEUTICS, INC. filing history →

Source: SEC EDGAR
accession 0001193125-25-125860
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.